BridgeBio Pharma, Inc. (BBIO) › Total AssetsBridgeBio Pharma, Inc. (BBIO) — Total AssetsAnnual figures by period end, from SEC filings.2018-12-31: $464.94M2019-12-31: $631.68M2020-12-31: $703.59M2021-12-31: $1.01B2022-12-31: $623.04M2023-12-31: $546.38M2024-12-31: $919.34M2025-12-31: $936.02M$936.02M2018-12-31Total Assets (USD)2025-12-31Period endedTotal AssetsChange YoYSource filing2025-12-31$936.02M+1.8%2026-02-24Balance as of period end2024-12-31$919.34M+68.3%2026-02-24Balance as of period end2023-12-31$546.38M-12.3%2025-02-20Balance as of period end2022-12-31$623.04M-38.5%2024-02-22Balance as of period end2021-12-31$1.01B+43.9%2023-02-23Balance as of period end2020-12-31$703.59M+11.4%2022-02-25Balance as of period end2019-12-31$631.68M+35.9%2021-02-25Balance as of period end2018-12-31$464.94M—2020-03-03Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)